ESR1 and breast carcinoma: Signal transduction pathways drive tumor growth and metastasis, either as a single active pathway (e.g., the ER pathway in luminal A breast cancer) or through cooperation or crosstalk between signaling pathways (e.g., the MAPK and TGFβ pathways) (Sundqvist et al., 2013).